2026 ICD-10-CM Diagnosis Code T44.4X1SPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela

ICD-10-CM CodesS00–T88T36-T50T44

ICD-10-CM T44.4X1S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T44.4X1S is a billable ICD-10-CM diagnosis code for poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T44.4X1S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela
Short Description
Poisoning by predom alpha-adrenocpt agonists, acc, sequela
Parent Code
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT44Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system
This CodeT44.4X1SPoisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela

Present on Admission (POA)Billing

T44.4X1S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental metaraminol overdose
  • Accidental metaraminol poisoning
  • Accidental poisoning by adrenergics
  • Accidental poisoning by norepinephrine
  • Alpha-adrenoceptor agonist overdose
  • Alpha-adrenoceptor agonist poisoning
  • Central alpha-2 adrenergic receptor agonist overdose
  • Central alpha-2 adrenergic receptor agonist poisoning
  • Metaraminol overdose
  • Poisoning by metaraminol
  • Poisoning caused by norepinephrine
  • Vasopressor drug overdose

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system (T44). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Etilefrine

    a phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
  • Metaraminol

    a sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. it has been used primarily as a vasoconstrictor in the treatment of hypotension.
  • Methoxamine

    an alpha-1 adrenergic agonist that causes prolonged peripheral vasoconstriction.
  • Norepinephrine

    precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the locus ceruleus. it is also found in plants and is used pharmacologically as a sympathomimetic.
  • Norepinephrine Plasma Membrane Transport Proteins

    sodium chloride-dependent neurotransmitter symporters located primarily on the plasma membrane of noradrenergic neurons. they remove norepinephrine from the extracellular space by high affinity reuptake into presynaptic terminals. the norepinephrine transporter regulates signal amplitude and duration at noradrenergic synapses and is the target of adrenergic uptake inhibitors.
  • Phenylethanolamine N-Methyltransferase

    a methyltransferase that catalyzes the reaction of s-adenosyl-l-methionine and phenylethanolamine to yield s-adenosyl-l-homocysteine and n-methylphenylethanolamine. it can act on various phenylethanolamines and converts norepinephrine into epinephrine. (from enzyme nomenclature, 1992) ec 2.1.1.28.
  • Receptors, Adrenergic

    cell-surface proteins that bind epinephrine and/or norepinephrine with high affinity and trigger intracellular changes. the two major classes of adrenergic receptors, alpha and beta, were originally discriminated based on their cellular actions but now are distinguished by their relative affinity for characteristic synthetic ligands. adrenergic receptors may also be classified according to the subtypes of g-proteins with which they bind; this scheme does not respect the alpha-beta distinction.
  • Phenylephrine

    an alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AgonistT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
Agonist::predominantlyT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
Agonist::predominantly::alpha-adrenoreceptorT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
Agonist::predominantly::beta-adrenoreceptorT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
AplonidineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
Apraclonidine (hydrochloride)T44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
CyclopentamineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
EtilefrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
GepefrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
LevarterenolT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
MetaraminolT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
MethoxamineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
NoradrenalineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
NorepinephrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
NorfenefrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
OxedrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
ParedrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
PhenylephrineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6
PrivineT44.4X1T44.4X2T44.4X3T44.4X4T44.4X5T44.4X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T44.4X1S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E929.2 Late eff acc poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T44.4X1SOverview

Is T44.4X1S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T44.4X1S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional) itself has resolved, not the original event.

What MS-DRG does T44.4X1S group to?

When poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T44.4X1S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela on inpatient claims.

What is the ICD-9 equivalent of T44.4X1S?

Under the General Equivalence Mappings, poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E929.2 (late eff acc poisoning). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.